Regeneron Pharmaceuticals (REGN) Retained Earnings (2009 - 2026)
Regeneron Pharmaceuticals' quarterly Retained Earnings came in at $36.4 billion in Q1 2026, up 12.47% year-on-year from $32.4 billion in Q1 2025, and up 46898.45% quarter-over-quarter from $77.5 million in Q4 2025.
Regeneron Pharmaceuticals has reported Retained Earnings for 18 years, with the latest figure at $36.4 billion in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings rose 12.47% year-over-year to $36.4 billion; the trailing twelve-month figure through Mar 2026 stood at $36.4 billion (up 12.47% YoY), and the FY2025 full-year result was $77.5 million, down 99.76% from the prior year.
- Retained Earnings for Q1 2026 stood at $36.4 billion, up from $77.5 million in the prior quarter.
- The five-year high for Retained Earnings was $36.4 billion in Q1 2026, with the low at -$275.1 million in Q3 2022.
- Average Retained Earnings over 5 years is $16.0 billion, with a median of $23.3 billion recorded in 2022.
- Peak annual rise in Retained Earnings reached 89056.87% in 2022, while the deepest fall reached 101.64% in 2022.
- Tracing REGN's Retained Earnings over 5 years: stood at $23.3 billion in 2022, then climbed by 16.96% to $27.3 billion in 2023, then rose by 16.19% to $31.7 billion in 2024, then plunged by 99.76% to $77.5 million in 2025, then surged by 46898.45% to $36.4 billion in 2026.
- The last three Retained Earnings figures came in at $36.4 billion (Q1 2026), $77.5 million (Q4 2025), and $35.0 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -622,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 36.42 Bn |
| Dec 31, 2025 | 77.50 Mn |
| Sep 30, 2025 | 35.05 Bn |
| Jun 30, 2025 | 33.68 Bn |
| Mar 31, 2025 | 32.38 Bn |
| Dec 31, 2024 | 31.67 Bn |
| Sep 30, 2024 | 60.20 Mn |
| Jun 30, 2024 | 29.41 Bn |
| Mar 31, 2024 | -77.20 Mn |
| Dec 31, 2023 | 27.26 Bn |
| Sep 30, 2023 | -176.80 Mn |
| Jun 30, 2023 | -197.70 Mn |
| Mar 31, 2023 | 24.12 Bn |
| Dec 31, 2022 | 23.31 Bn |
| Sep 30, 2022 | -275.10 Mn |
| Jun 30, 2022 | -223.80 Mn |
| Mar 31, 2022 | -170.10 Mn |
| Dec 31, 2021 | -26.20 Mn |
| Sep 30, 2021 | 16.74 Bn |
| Jun 30, 2021 | 15.11 Bn |
| Mar 31, 2021 | 12.01 Bn |
| Dec 31, 2020 | 10.89 Bn |
| Sep 30, 2020 | 30.80 Mn |
| Jun 30, 2020 | 8.90 Bn |
| Mar 31, 2020 | 8.00 Bn |
| Dec 31, 2019 | 7.38 Bn |
| Sep 30, 2019 | 16.50 Mn |
| Jun 30, 2019 | 5.92 Bn |
| Mar 31, 2019 | 5.73 Bn |
| Dec 31, 2018 | 5.25 Bn |
| Sep 30, 2018 | 4.43 Bn |
| Jun 30, 2018 | -11.61 Mn |
| Mar 31, 2018 | -15.59 Mn |
| Dec 31, 2017 | 600,000.00 |
| Sep 30, 2017 | 2.77 Bn |
| Jun 30, 2017 | 2.35 Mn |
| Mar 31, 2017 | -5.88 Mn |
| Dec 31, 2016 | -12.84 Mn |
| Sep 30, 2016 | -2.90 Mn |
| Jun 30, 2016 | 1.23 Bn |
| Mar 31, 2016 | 4.36 Mn |
| Dec 31, 2015 | 8.57 Mn |
| Sep 30, 2015 | 697.71 Mn |
| Jun 30, 2015 | 19.15 Mn |
| Mar 31, 2015 | 47.90 Mn |
| Dec 31, 2014 | 52.25 Mn |
| Sep 30, 2014 | 26.90 Mn |
| Jun 30, 2014 | 4.26 Mn |
| Mar 31, 2014 | 1.47 Mn |
| Dec 31, 2013 | -1.19 Mn |
| Sep 30, 2013 | -189.50 Mn |
| Jun 30, 2013 | -330.80 Mn |
| Mar 31, 2013 | -1.64 Mn |
| Dec 31, 2012 | -517.05 Mn |
| Sep 30, 2012 | -987.46 Mn |
| Jun 30, 2012 | -2.37 Mn |
| Mar 31, 2012 | -1.26 Bn |
| Dec 31, 2011 | -1.27 Bn |
| Sep 30, 2011 | -1.21 Bn |
| Jun 30, 2011 | -1.15 Bn |
| Mar 31, 2011 | -1.09 Bn |
| Dec 31, 2010 | -1.05 Bn |
| Sep 30, 2010 | -175,000.00 |
| Jun 30, 2010 | -306,000.00 |
| Dec 31, 2009 | -941.10 Mn |